WuXi Biologics (02269.HK) spent 299 million Hong Kong dollars on July 8th to buy back 11.68 million shares.
The Wealth China Financial App reported that WuXi Biologics (02269.HK) has announced on July 8, 2025 that the company will spend 299 million Hong Kong dollars to repurchase 11.68 million shares at a repurchase price of 25.2-25.8 Hong Kong dollars per share.
Latest